Menu
GeneBe

PLXND1

plexin D1, the group of Plexins|IPT domain containing

Basic information

Region (hg38): 3:129555213-129606676

Links

ENSG00000004399NCBI:23129OMIM:604282HGNC:9107Uniprot:Q9Y4D7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • Mobius syndrome (Supportive), mode of inheritance: AD
  • persistent truncus arteriosus (Supportive), mode of inheritance: AR
  • congenital heart defects, multiple types, 9 (Limited), mode of inheritance: AR
  • congenital heart defects, multiple types, 9 (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Congenital heart defects, multiple types, 9ARCardiovascularThe condition can involve congenital cardiac anomalies, and awareness may allow early managementCardiovascular24254849; 34791216; 35396997

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PLXND1 gene.

  • not provided (103 variants)
  • Inborn genetic diseases (85 variants)
  • not specified (2 variants)
  • Congenital heart defects, multiple types, 9 (1 variants)
  • Oromandibular-limb hypogenesis spectrum (1 variants)
  • Kleine-Levin syndrome (1 variants)
  • PLXND1-related condition (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLXND1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
42
clinvar
10
clinvar
52
missense
92
clinvar
13
clinvar
14
clinvar
119
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
11
3
14
non coding
3
clinvar
4
clinvar
7
Total 0 0 92 58 28

Variants in PLXND1

This is a list of pathogenic ClinVar variants found in the PLXND1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-129556323-T-C not specified Uncertain significance (Mar 25, 2022)2279806
3-129556363-C-T PLXND1-related disorder Benign (Jun 06, 2019)3059889
3-129556419-C-T Likely benign (Dec 31, 2019)719076
3-129556632-C-T PLXND1-related disorder Likely benign (Jul 15, 2019)3050325
3-129556637-C-T not specified Uncertain significance (Jun 11, 2021)2205479
3-129556638-G-A PLXND1-related disorder Likely benign (Jun 11, 2019)3033777
3-129556649-T-C Kleine-Levin syndrome Uncertain significance (Oct 19, 2017)1810414
3-129557119-C-A not specified Uncertain significance (Jul 12, 2022)2411009
3-129557121-C-T not specified Uncertain significance (May 23, 2023)2527111
3-129557172-T-C not specified Uncertain significance (Jun 29, 2023)2607249
3-129557179-C-T Likely benign (Dec 31, 2019)736030
3-129557229-C-CAGAG PLXND1-related disorder Likely benign (Jul 08, 2019)722559
3-129558550-T-A Congenital heart defects, multiple types, 9 Pathogenic (Mar 22, 2023)2445604
3-129558550-T-C not specified Uncertain significance (Feb 24, 2022)2277921
3-129559661-T-G Likely benign (Aug 20, 2018)765142
3-129560322-G-A Likely benign (May 15, 2018)727469
3-129560323-G-A Likely benign (Mar 30, 2018)736978
3-129560382-T-C not specified Uncertain significance (May 04, 2022)978156
3-129560419-C-G not specified Uncertain significance (Jul 20, 2021)2399087
3-129560420-G-A Likely benign (Mar 30, 2018)747472
3-129560431-G-T PLXND1-related disorder Benign (Dec 31, 2019)708884
3-129560439-G-C Likely benign (Jul 05, 2018)749605
3-129560727-T-C PLXND1-related disorder Benign (Jun 06, 2019)3060610
3-129561636-C-T Likely benign (Dec 26, 2018)797358
3-129561670-T-C not specified Uncertain significance (Feb 07, 2023)2482017

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PLXND1protein_codingprotein_codingENST00000324093 3651644
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.004.40e-91257270211257480.0000835
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.358211.14e+30.7210.000073312310
Missense in Polyphen254473.980.535885136
Synonymous0.1194975000.9930.00003523922
Loss of Function7.78783.90.08350.00000415920

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00008890.0000889
Ashkenazi Jewish0.0003980.000397
East Asian0.0001110.000109
Finnish0.00004640.0000462
European (Non-Finnish)0.00007100.0000703
Middle Eastern0.0001110.000109
South Asian0.00009880.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Cell surface receptor for SEMA4A and for class 3 semaphorins, such as SEMA3A, SEMA3C and SEMA3E. Plays an important role in cell-cell signaling, and in regulating the migration of a wide spectrum of cell types. Regulates the migration of thymocytes in the medulla. Regulates endothelial cell migration. Plays an important role in ensuring the specificity of synapse formation. Required for normal development of the heart and vasculature (By similarity). Mediates anti-angiogenic signaling in response to SEMA3E. {ECO:0000250, ECO:0000269|PubMed:20385769}.;
Pathway
Angiogenesis overview;miR-targeted genes in leukocytes - TarBase;miR-targeted genes in lymphocytes - TarBase;Developmental Biology;Signal Transduction;NOTCH3 Intracellular Domain Regulates Transcription;Signaling by NOTCH3;Signaling by NOTCH;Other semaphorin interactions;Semaphorin interactions;Plexin-D1 Signaling;Axon guidance (Consensus)

Recessive Scores

pRec
0.126

Intolerance Scores

loftool
0.160
rvis_EVS
-1.31
rvis_percentile_EVS
4.88

Haploinsufficiency Scores

pHI
0.156
hipred
Y
hipred_score
0.682
ghis
0.595

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.167

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumHigh
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Plxnd1
Phenotype
hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; embryo phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; digestive/alimentary phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype;

Zebrafish Information Network

Gene name
plxnd1
Affected structure
fat cell
Phenotype tag
abnormal
Phenotype quality
increased process quality

Gene ontology

Biological process
angiogenesis;branching involved in blood vessel morphogenesis;outflow tract morphogenesis;cardiac septum development;negative regulation of cell adhesion;positive regulation of transcription of Notch receptor target;synapse assembly;regulation of cell shape;regulation of cell migration;positive regulation of protein binding;aorta development;regulation of GTPase activity;endothelial cell migration;regulation of angiogenesis;positive regulation of axonogenesis;dichotomous subdivision of terminal units involved in salivary gland branching;coronary vasculature development;semaphorin-plexin signaling pathway;semaphorin-plexin signaling pathway involved in axon guidance
Cellular component
semaphorin receptor complex;plasma membrane;integral component of plasma membrane;lamellipodium;lamellipodium membrane
Molecular function
protein binding;semaphorin receptor activity;protein domain specific binding